Abbott Laboratories CEO calls post-earnings stock decline 'a little bit of an overreaction'
Abbott Laboratories CEO Robert Ford unpacked his company's latest quarterly report in a Thursday interview with CNBC's Jim Cramer.
0 Comments
Comments 0
No comments yet. Be the first to comment!